Bluebird Bio, Inc. Share Price

NASDAQ: BLUE

$4.97

as on May 31, 2025 at 1:29 am IST

$₹

The stock has been delisted from the stock exchange on 30 May 2025

Bluebird Bio, Inc. Stock Performance

as on May 31, 2025 at 1:29 am IST

$4.97
Day's Price Range
$4.97
$4.97
52 Week's Low
52 Week's High
$3.2
52-Week Price Range
$151.2
$4.97
35.61%
Downside
2942.25%
Upside

Bluebird Bio, Inc. share price movements today

Previous Close: $4.97
Open: $4.97
Volume: 100.0
Day's Low - High: $4.97 - $4.97
52 Week Low - High: $3.2 - $151.2

Bluebird Bio, Inc. Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Bluebird Bio, Inc. Stock Fundamentals & Key Indicators

Check Bluebird Bio, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

0.00%

Bluebird Bio, Inc. stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Bluebird Bio, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Bluebird Bio, Inc.	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Bluebird Bio, Inc. Stock

Based on 20 analysts

BUY

50.00%

Buy

40.00%

Hold

10.00%

Sell

Based on 20 analysts, 50% of analysts recommend a 'BUY' rating for Bluebird Bio, Inc.. Average target price of $8

Bluebird Bio, Inc. Share Price Target

Get share price movements and forecasts by analysts on Bluebird Bio, Inc..

What analysts predicted

37.88%UPSIDE

Target Price

Current Price

$4.97

Analyzed by

20 Analysts

Target

$8.00

Bluebird Bio, Inc. target price $8, a slight upside of 37.88% compared to current price of $4.97. According to 20 analysts rating.

Bluebird Bio, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	0	2	6	12	7	18	16	10	38	38
Gross Profit	0	0	-2	1	-1	-7	-12	-1	15	26
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	32	34	-72	-71	-88	-69	-81	-60	-28	-29
Net Profit Margin	51987.10%	1429.78%	-1058.17%	-578.85%	-1129.87%	-375.84%	-505.52%	-573.01%	-74.54%	-75.09%

Bluebird Bio, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	14	6	35	54	44	250	3	3	29	83
Gross Profit	-109	-198	33	53	41	245	-35	-6	-4	-5
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-166	-263	-335	-555	-789	-618	-562	-266	-211	-240
Net Profit Margin	-1184.62%	-4281.19%	-947.42%	-1018.02%	-1767.49%	-246.75%	-15364.23%	-7411.12%	-718.42%	-287.23%

Global Institutional Holdings in Bluebird Bio, Inc.

Funds	Holdings
BlackRock Inc	7.13%
Vanguard Group Inc	5.29%
TANG CAPITAL MANAGEMENT LLC	4.08%
Geode Capital Management, LLC	2.51%
State Street Corp	2%

See all

About Bluebird Bio, Inc.

bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. It markets three gene therapies: ZYNTEGLO (betibeglogene autotemcel, also known as beti-cel), SKYSONA (elivaldogene autotemcel, also known as eli-cel), and LYFGENIA (lovotibeglogene autotemcel, also known as lovo-cel). ZYNTEGLO is the first gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions. SKYSONA is used to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). LYFGENIA is used for the treatment of sickle cell disease in patients ages 12 and older who have a history of vaso-occlusive events (VOEs).

Organisation	Bluebird Bio, Inc.
E-voting on shares	Click here to vote

FAQs

What is Bluebird Bio, Inc. share price today?

Bluebird Bio, Inc. share price today is $4.97 as on May 31, 2025 at 1:29 am IST at the close of the market. Bluebird Bio, Inc. share today touched a day high of $4.97 and a low of $4.97.

What is the 52 week high and 52 week low for Bluebird Bio, Inc. share?

Bluebird Bio, Inc. share touched a 52 week high of $151.2 on December 13, 2024 and a 52 week low of $3.2 on May 13, 2025. Bluebird Bio, Inc. stock price today i.e. May 31, 2025 at 1:29 am IST is closed at $4.97,which is 96.71% down from its 52 week high and 55.31% up from its 52 week low.

How to invest in Bluebird Bio, Inc. Stock (BLUE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Bluebird Bio, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bluebird Bio, Inc. Shares that will get you 0.3018 shares as per Bluebird Bio, Inc. share price of $4.97 per share as on May 31, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bluebird Bio, Inc. Stock (BLUE) from India?

Indian investors can start investing in Bluebird Bio, Inc. (BLUE) shares with as little as ₹88.27 or $1 (as of September 15, 2025 at 1:11 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Bluebird Bio, Inc. stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 1:11 am IST). Based on Bluebird Bio, Inc. share’s latest price of $4.97 as on May 31, 2025 at 1:29 am IST, you will get 2.0121 shares of Bluebird Bio, Inc.. Learn more about fractional shares .